Acute Renal Insufficiency (ARI) Rate and Predictive Score of ARI in Hospitalized Patients for Acute Coronary Syndrome With ST-segment Elevation Needing Urgent Coronarography

NCT ID: NCT04481126

Last Updated: 2021-09-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

168 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-01

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of the study aims to evaluate frequence of acute renal insufficiency in patients with ST-segment elevation who need urgent coronary angiography in Ambroise Paré hospital.

The secondary objectives are:

* identify factors of risks associated with the occurrence of acute renal insufficiency after coronarography.
* establish a preprocedure score, predicting of acute renal insufficiency after urgent coronary angiography in patients with ST+ acute coronary syndrome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Renal Insufficiency Acute Coronary Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patient aged ≥ 18 years;
* evocative symptoms of myocardiac ischemia: typical chest pain; ST-segment elevation and 1 mm in two consecutive peripheral leads and 2 mm in two consecutive precordial derivations, or appearance of a bloc of left branch of novo;
* need urgent coronarography;
* Covered by french social security scheme included CMU.

Exclusion Criteria

* dialysed patient for chronic renal insufficiency;
* cardio-resporatory arrest;
* cardiogenic choc state;
* prior emergency passage to hospital;
* patient under tutor, gardianship;
* patient covered by french AME scheme;
* pregnant women or breastfeeding;
* all medical, psychological or social situation which should influents the compliance to protocol according to investigator;
* patient refusal.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul GABARRE, MD

Role: PRINCIPAL_INVESTIGATOR

Nephrology department, Ambroise Paré hospital, APHP

Eve Vilaine, MD

Role: STUDY_DIRECTOR

Nephrology department, Ambroise Paré hospital, APHP

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nephrology department, Ambroise Paré hospital, APHP

Boulogne-Billancourt, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Paul GABARRE, MD

Role: CONTACT

+33 (0)1 49 09 56 45

Eve Vilaine, MD

Role: CONTACT

+33 (0)1 49 09 56 45

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

APHP201021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ultra-Low Contrast Angiography in AKI
NCT05906758 RECRUITING PHASE3